EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Multicenter evaluation of linezolid antimicrobial activity in North America



Multicenter evaluation of linezolid antimicrobial activity in North America



Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 40: 186




(PDF 0-2 workdays service: $29.90)

Accession: 035349797

Download citation: RISBibTeXText



Related references

A multicenter evaluation of linezolid antimicrobial activity in North America. Diagnostic Microbiology & Infectious Disease 43(1): 75-83, 2002

Multicenter assessment of the linezolid spectrum and activity using the disk diffusion and Etest methods: report of the Zyvox(R) antimicrobial potency study in Latin America (LA-ZAPS). Brazilian Journal of Infectious Diseases 6(3): 100-109, 2002

Comparative evaluation of frequencies and antimicrobial susceptibilities of pathogens isolated from urinary tract infection in North America and Latin America Results of the SENTRY Antimicrobial Surveillance Program, 1997-. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 38: 179, 1998

Evaluation of the antimicrobial activity of daptomycin and linezolid against vancomycin-resistant Enterococcus spp. isolates in south India. Journal of Global Antimicrobial Resistance 2(3): 194-197, 2014

Molecular analysis and activity profiles of fluoroquinolone -resistant S pneumoniae isolates from North America , Latin America and Europe Results from the SENTRY Antimicrobial Surveillance Program. Abstracts Of The Interscience Conference On Antimicrobial Agents & Chemotherapy. 43: 121, 2003

Multicenter evaluation of the antimicrobial activity for seven broad-spectrum beta-lactams in Turkey using the Etest method. Turkish Antimicrobial Resistance Study Group. Diagnostic Microbiology and Infectious Disease 35(1): 65-73, 1999

Multicenter evaluation of the antimicrobial activity for six broad-spectrum beta-lactams in Venezuela using the Etest method. The Venezuelan Antimicrobial Resistance Study Group. Diagnostic Microbiology and Infectious Disease 30(1): 45-52, 1998

Antimicrobial activity of broad-spectrum agents tested against Gram-negative bacilli resistant to ceftazidime: report from the SENTRY Antimicrobial Surveillance Program (North America, 2001). Diagnostic Microbiology and Infectious Disease 44(4): 379-382, 2003

Antimicrobial activity of broad-spectrum agents tested against Gram-negative bacilli resistant to ceftazidime: Report from the SENTRY Antimicrobial Surveillance Program (North America, 2001). Diagnostic Microbiology and Infectious Disease 44(4): 379-382, 2002

Prevalence and antimicrobial susceptibility patterns among gastroenteritis-causing pathogens recovered in Europe and Latin America and Salmonella isolates recovered from bloodstream infections in North America and Latin America: report from the SENTRY Antimicrobial Surveillance Program (2003). International Journal of Antimicrobial Agents 27(5): 367-375, 2006

Antimicrobial Susceptibility Among Gram-Negative Isolates Collected From Intensive Care Units in North America, Europe, the Asia-Pacific Rim, Latin America, the Middle East, and Africa Between 24 and 29 as Part of the Tigecycline Evaluation and Survei. 2011

Multicenter evaluation of the antimicrobial activity for six broad-spectrum beta-lactams in Venezuela: comparison of data from 1997 and 1998 using the Etest method. Venezuelan Antimicrobial Resistance Study Group. Diagnostic Microbiology and Infectious Disease 35(2): 153-158, 1999

Carbapenem and cefepime activity tested against ceftazidime- and ceftriaxone-resistant Enterobacter spp isolates from North America , Latin America , Asia-Pacific , and Europe , 1997-2000 Report from the SENTRY antimicrobial surveillance program. Abstracts of the General Meeting of the American Society for Microbiology 102: 7, 2002

Antifungal activity of BMS-207147, a new triazole antifungal agent, tested against 613 blood stream isolates of Candida spp from the SENTRY Antimicrobial Surveillance Program in North America and Latin America, 1997 and 1998. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 39: 341, 1999